Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Teva's Allergic Rhinitis Drug Study Shows Significantly Greater Symptom Relief
Stock Markets Review
Monday, November 15, 2010 - 11:01am
tags:
Teva Pharmaceuticals, allergic rhinitis, QNAZE
Sanofi's Shantha Deal Fails to Bring Viehbacher a Sales Boost
Bloomberg
Monday, November 15, 2010 - 10:59am
tags:
Chris Viehbacher, Sanofi, Shantha Biotech
Provenge & The Medicare Meeting: Sean Tunis Explains
Pharmalot
Monday, November 15, 2010 - 10:55am
tags:
Provenge, Medicare, prostate cancer, Dendreon
Human Genome, StemCells lead drug stocks
Marketwatch
Monday, November 15, 2010 - 10:53am
tags:
drug stocks, StemCells, Human Genome Sciences
Is Illumina Earning Its Keep?
Motley Fool
Monday, November 15, 2010 - 10:52am
tags:
Illumina
Lilly Ventures leads $24M round for Cerulean's PhII
Fierce Biotech
Monday, November 15, 2010 - 10:51am
tags:
Eli Lilly, financing, Cerulean, Series C, lung cancer
Benlysta review spooks investors ahead of FDA panel
Fierce Biotech
Monday, November 15, 2010 - 10:48am
tags:
FDA, advisory panels, Benlysta, Human Genome Sciences, lupus
At AstraZeneca, 15,000 Layoffs May Not Be Enough
BNET Pharma
Monday, November 15, 2010 - 10:42am
tags:
layoffs, AstraZeneca
Bayer Sees $2.73 Billion Peak Xarelto Sales as ’Conservative’
Bloomberg
Monday, November 15, 2010 - 10:40am
tags:
Bayer, Xarelto, blood thinners
Genzyme in Talks to Sell Itself to Japan’s Takeda, Mail Says
Bloomberg
Monday, November 15, 2010 - 10:39am
tags:
Takeda, Genzyme, M&A
UCB Falls Most in Six Months as UBS Downgrades, Says Takeover Is Unlikely
Bloomberg
Monday, November 15, 2010 - 10:38am
tags:
UCB Pharmaceuticals, M&A, Cimzia, Pfizer, rheumatoid arthritis
AstraZeneca Defeats Teva's Unusual Patent Claim
Seeking Alpha
Monday, November 15, 2010 - 10:37am
tags:
Teva Pharmaceuticals, patents, AstraZeneca, Crestor
Surprise: JNJ Heart Drug Doesn’t Kill People. Or Do Much Of Anything.
Forbes
Sunday, November 14, 2010 - 1:31pm
tags:
JNJ, congestive heart failure, Natrecor
Moody’s Downgrade Adds to Eli Lilly's Growing Burden
Seeking Alpha
Sunday, November 14, 2010 - 1:30pm
tags:
Eli Lilly
Big pharma’s Brazilian prescription
Financial Times, UK
Sunday, November 14, 2010 - 1:29pm
tags:
Big Pharma, Brazil
Morgan Stanley unenthusiastic on Teva share
Globes, Israel
Sunday, November 14, 2010 - 1:28pm
tags:
Teva Pharmaceuticals
Avanir Pharmaceuticals (AVNR) Institutional Ownership Increases
Wall Street NewsCast
Sunday, November 14, 2010 - 1:27pm
tags:
Avanir
AcelRx Pharmaceuticals Files Registration Statement for Proposed Initial Public Offering
PR-USA.net
Sunday, November 14, 2010 - 1:25pm
tags:
AcelRx, pain management
MethylGene Reports Third Quarter 2010 Financial Results and Provides Clinical Update for MGCD265
PR-USA.net
Sunday, November 14, 2010 - 1:09pm
tags:
MethylGene, earnings, Otsuka, MGCD265, cancer
London Genetics and Astrimmune to Collaborate on Cancer Vaccine
PipeLine Review
Sunday, November 14, 2010 - 1:06pm
tags:
London Genetics, Astrimmune, cancer vaccines

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.